137 related articles for article (PubMed ID: 8718849)
1. Structural change in alpha-chymotrypsin induced by complexation with alpha 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis.
Stavridi ES; O'Malley K; Lukacs CM; Moore WT; Lambris JD; Christianson DW; Rubin H; Cooperman BS
Biochemistry; 1996 Aug; 35(33):10608-15. PubMed ID: 8718849
[TBL] [Abstract][Full Text] [Related]
2. Antichymotrypsin interaction with chymotrypsin. Partitioning of the complex.
Cooperman BS; Stavridi E; Nickbarg E; Rescorla E; Schechter NM; Rubin H
J Biol Chem; 1993 Nov; 268(31):23616-25. PubMed ID: 7693693
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
4. Conversion of alpha 1-antichymotrypsin into a human neutrophil elastase inhibitor: demonstration of variants with different association rate constants, stoichiometries of inhibition, and complex stabilities.
Rubin H; Plotnick M; Wang ZM; Liu X; Zhong Q; Schechter NM; Cooperman BS
Biochemistry; 1994 Jun; 33(24):7627-33. PubMed ID: 8011628
[TBL] [Abstract][Full Text] [Related]
5. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
7. Substrate and inhibitor-induced conformational changes in the structurally related enzymes UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate 3-phosphate synthase (EPSPS).
Krekel F; Oecking C; Amrhein N; Macheroux P
Biochemistry; 1999 Jul; 38(28):8864-78. PubMed ID: 10413459
[TBL] [Abstract][Full Text] [Related]
8. Distortion of the active site of chymotrypsin complexed with a serpin.
Plotnick MI; Mayne L; Schechter NM; Rubin H
Biochemistry; 1996 Jun; 35(23):7586-90. PubMed ID: 8652540
[TBL] [Abstract][Full Text] [Related]
9. Antichymotrypsin interaction with chymotrypsin. Reactions following encounter complex formation.
Nair SA; Cooperman BS
J Biol Chem; 1998 Jul; 273(28):17459-62. PubMed ID: 9651334
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
Czapinska H; Helland R; Smalås AO; Otlewski J
J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
[TBL] [Abstract][Full Text] [Related]
11. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin.
Plotnick MI; Rubin H; Schechter NM
J Biol Chem; 2002 Aug; 277(33):29927-35. PubMed ID: 12055188
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
[TBL] [Abstract][Full Text] [Related]
13. The primary elastase inhibitor (elastasin) and trypsin inhibitor (contrapsin) in the goat are serpins related to human alpha 1-anti-chymotrypsin.
Potempa J; Enghild JJ; Travis J
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):191-7. PubMed ID: 7864809
[TBL] [Abstract][Full Text] [Related]
14. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
[TBL] [Abstract][Full Text] [Related]
16. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic proteolytic enzymes of ostrich purified on immobilized protein inhibitors. Characterization of a new form of chymotrypsin (Chtr1).
Zelazko M; Chrzanowska J; Polanowski A
Comp Biochem Physiol B Biochem Mol Biol; 2008 Sep; 151(1):102-9. PubMed ID: 18598777
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
Capasso C; Rizzi M; Menegatti E; Ascenzi P; Bolognesi M
J Mol Recognit; 1997; 10(1):26-35. PubMed ID: 9179777
[TBL] [Abstract][Full Text] [Related]
19. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
20. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
